Data spanning the past 90 days through February 19, 2026 reveals that NovaBay Pharmaceuticals's three principal insider shareholders consist of TenPercentOwner Ventures Iv L.P. Framework (56.81Mn shares), Chief Executive Officer Michael John Kazley (56.81Mn shares), TenPercentOwner Fund Lp R01 (56.81Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Ventures Iv L.P. Framework | 56,806,080 | 03 Nov, 2025 | |
| Fund Lp R01 | 56,806,080 | 03 Nov, 2025 | |
| Michael John Kazley | Chief Executive Officer | 56,806,080 | 03 Nov, 2025 |
| Point Capital Partners Lp Poplar | 1,020,300 | 14 Apr, 2025 | |
| Andrew D. Jones | Cfo | 3 | 06 Dec, 2021 |
| Justin Hall | Ceo And Gc And Director | 2 | 16 Sep, 2022 |
| Swan Sit | 49 | 15 May, 2023 | |
| Paul E. Freiman | 49 | 15 May, 2023 | |
| Mijia Wu | 49 | 15 May, 2023 | |
| Yenyou Zheng | 49 | 15 May, 2023 | |
| Yongxiang Zheng | 25 | 15 May, 2023 | |
| Julie Garlikov | 25 | 15 May, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 21 Oct, 2025 | Fund Lp R01 | Common Stock | A | 56,806,080 | $0.00 | 56,806,080 | D | C |
| 21 Oct, 2025 | Ventures Iv L.P. Framework | Common Stock | A | 56,806,080 | $0.00 | 56,806,080 | D | C |
| 21 Oct, 2025 | Michael John Kazley | Common Stock | A | 56,806,080 | $0.00 | 56,806,080 | I | C |
| 08 Apr, 2025 | Point Capital Partners Lp Poplar | - | - | 1,020,300 | D | |||
| 08 Apr, 2025 | Point Capital Partners Lp Poplar | Common Stock, par value $0.01 per share | A | 300 | $0.46 | 1,020,300 | D | P |
| 04 Apr, 2025 | Point Capital Partners Lp Poplar | Common Stock, par value $0.01 per share | A | 4,538 | $0.52 | 1,020,000 | D | P |
| 04 Apr, 2025 | Point Capital Partners Lp Poplar | - | - | 1,020,000 | D | |||
| 03 Apr, 2025 | Point Capital Partners Lp Poplar | Common Stock, par value $0.01 per share | A | 22,976 | $0.56 | 1,015,462 | D | P |
| 03 Apr, 2025 | Point Capital Partners Lp Poplar | - | - | 1,015,462 | D | |||
| 02 Apr, 2025 | Point Capital Partners Lp Poplar | Common Stock, par value $0.01 per share | A | 917 | $0.58 | 992,486 | D | P |
| 02 Apr, 2025 | Point Capital Partners Lp Poplar | - | - | 992,486 | D | |||
| 01 Apr, 2025 | Point Capital Partners Lp Poplar | Common Stock, par value $0.01 per share | A | 19,915 | $0.58 | 991,569 | D | P |
| 31 Mar, 2025 | Point Capital Partners Lp Poplar | Common Stock, par value $0.01 per share | A | 21,654 | $0.59 | 971,654 | D | P |
| 28 Mar, 2025 | Point Capital Partners Lp Poplar | Common Stock, par value $0.01 per share | A | 49,400 | $0.61 | 950,000 | D | P |
| 27 Mar, 2025 | Point Capital Partners Lp Poplar | Common Stock, par value $0.01 per share | A | 18,504 | $0.62 | 900,000 | D | P |
| 27 Mar, 2025 | Point Capital Partners Lp Poplar | Common Stock, par value $0.01 per share | A | 600 | $0.61 | 900,600 | D | P |
| 26 Mar, 2025 | Point Capital Partners Lp Poplar | Common Stock, par value $0.01 per share | A | 13,292 | $0.61 | 881,496 | D | P |
| 25 Mar, 2025 | Point Capital Partners Lp Poplar | Common Stock, par value $0.01 per share | A | 22,635 | $0.61 | 868,204 | D | P |
| 24 Mar, 2025 | Point Capital Partners Lp Poplar | Common Stock, par value $0.01 per share | A | 100 | $0.60 | 845,569 | D | P |
| 21 Mar, 2025 | Point Capital Partners Lp Poplar | Common Stock, par value $0.01 per share | A | 6,372 | $0.60 | 845,469 | D | P |